Parents Suggest Which Indicators of Progress and Outcomes Should be Measured in Young Children with Autism Spectrum Disorder / H. MCCONACHIE in Journal of Autism and Developmental Disorders, 48-4 (April 2018)  

Public ISBD [article]  inJournal of Autism and Developmental Disorders > 48-4 (April 2018) . - p.1041-1051 Titre : Parents Suggest Which Indicators of Progress and Outcomes Should be Measured in Young Children with Autism Spectrum Disorder Type de document : texte imprimé Auteurs : H. MCCONACHIE, Auteur ; N. LIVINGSTONE, Auteur ; C. MORRIS, Auteur ; Bryony BERESFORD, Auteur ; Ann LE COUTEUR, Auteur ; P. GRINGRAS, Auteur ; D. GARLAND, Auteur ; G. JONES, Auteur ; G. MACDONALD, Auteur ; K. WILLIAMS, Auteur ; Jeremy R. PARR, Auteur Article en page(s) : p.1041-1051 Langues : Anglais (eng) Mots-clés : Consultation  Measurement  Outcomes  Parents  Young children Index. décimale : PER Périodiques Résumé : Evaluation of interventions for children with autism spectrum disorder (ASD) is hampered by the multitude of outcomes measured and tools used. Measurement in research with young children tends to focus on core impairments in ASD. We conducted a systematic review of qualitative studies of what matters to parents. Parent advisory groups completed structured activities to explore their perceptions of the relative importance of a wide range of outcome constructs. Their highest ranked outcomes impacted directly on everyday life and functioning (anxiety, distress, hypersensitivity, sleep problems, happiness, relationships with brothers and sisters, and parent stress). Collaboration between professionals, researchers and parents/carers is required to determine an agreed core set of outcomes to use across evaluation research. En ligne : http://dx.doi.org/10.1007/s10803-017-3282-2 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=351 [article] Parents Suggest Which Indicators of Progress and Outcomes Should be Measured in Young Children with Autism Spectrum Disorder [texte imprimé] / H. MCCONACHIE, Auteur ; N. LIVINGSTONE, Auteur ; C. MORRIS, Auteur ; Bryony BERESFORD, Auteur ; Ann LE COUTEUR, Auteur ; P. GRINGRAS, Auteur ; D. GARLAND, Auteur ; G. JONES, Auteur ; G. MACDONALD, Auteur ; K. WILLIAMS, Auteur ; Jeremy R. PARR, Auteur . - p.1041-1051. Langues : Anglais (eng) in Journal of Autism and Developmental Disorders > 48-4 (April 2018) . - p.1041-1051 Mots-clés : Consultation  Measurement  Outcomes  Parents  Young children Index. décimale : PER Périodiques Résumé : Evaluation of interventions for children with autism spectrum disorder (ASD) is hampered by the multitude of outcomes measured and tools used. Measurement in research with young children tends to focus on core impairments in ASD. We conducted a systematic review of qualitative studies of what matters to parents. Parent advisory groups completed structured activities to explore their perceptions of the relative importance of a wide range of outcome constructs. Their highest ranked outcomes impacted directly on everyday life and functioning (anxiety, distress, hypersensitivity, sleep problems, happiness, relationships with brothers and sisters, and parent stress). Collaboration between professionals, researchers and parents/carers is required to determine an agreed core set of outcomes to use across evaluation research. En ligne : http://dx.doi.org/10.1007/s10803-017-3282-2 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=351

Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver's Quality of Life / Carmen Maria SCHRODER in Journal of Autism and Developmental Disorders, 49-8 (August 2019)  

Public ISBD [article]  inJournal of Autism and Developmental Disorders > 49-8 (August 2019) . - p.3218-3230 Titre : Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver's Quality of Life Type de document : texte imprimé Auteurs : Carmen Maria SCHRODER, Auteur ; B. A. MALOW, Auteur ; A. MARAS, Auteur ; R. D. MELMED, Auteur ; R. L. FINDLING, Auteur ; J. BREDDY, Auteur ; T. NIR, Auteur ; S. SHAHMOON, Auteur ; N. ZISAPEL, Auteur ; P. GRINGRAS, Auteur Article en page(s) : p.3218-3230 Langues : Anglais (eng) Mots-clés : Autism  Behavior  Children (pediatric)  Prolonged-release melatonin  Sleep Index. décimale : PER Périodiques Résumé : A randomized, 13-weeks, placebo-controlled double-blind study in 125 subjects aged 2-17.5 years with Autism Spectrum Disorder or Smith-Magenis syndrome and insomnia demonstrated efficacy and safety of easily-swallowed prolonged-release melatonin mini-tablets (PedPRM; 2-5 mg) in improving sleep duration and onset. Treatment effects on child behavior and caregiver's quality of life were evaluated. PedPRM treatment resulted in significant improvement in externalizing but not internalizing behavior (Strengths and Difficulties questionnaire; SDQ) compared to placebo (p = 0.021) with clinically-relevant improvements in 53.7% of PedPRM-treated versus 27.6% of placebo-treated subjects (p = 0.008). Caregivers' quality of life also improved with PedPRM versus placebo (p = 0.010) and correlated with the change in total SDQ (p = 0.0005). PedPRM alleviates insomnia-related difficulties, particularly externalizing behavior in the children, subsequently improving caregivers' quality of life. En ligne : http://dx.doi.org/10.1007/s10803-019-04046-5 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=403 [article] Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver's Quality of Life [texte imprimé] / Carmen Maria SCHRODER, Auteur ; B. A. MALOW, Auteur ; A. MARAS, Auteur ; R. D. MELMED, Auteur ; R. L. FINDLING, Auteur ; J. BREDDY, Auteur ; T. NIR, Auteur ; S. SHAHMOON, Auteur ; N. ZISAPEL, Auteur ; P. GRINGRAS, Auteur . - p.3218-3230. Langues : Anglais (eng) in Journal of Autism and Developmental Disorders > 49-8 (August 2019) . - p.3218-3230 Mots-clés : Autism  Behavior  Children (pediatric)  Prolonged-release melatonin  Sleep Index. décimale : PER Périodiques Résumé : A randomized, 13-weeks, placebo-controlled double-blind study in 125 subjects aged 2-17.5 years with Autism Spectrum Disorder or Smith-Magenis syndrome and insomnia demonstrated efficacy and safety of easily-swallowed prolonged-release melatonin mini-tablets (PedPRM; 2-5 mg) in improving sleep duration and onset. Treatment effects on child behavior and caregiver's quality of life were evaluated. PedPRM treatment resulted in significant improvement in externalizing but not internalizing behavior (Strengths and Difficulties questionnaire; SDQ) compared to placebo (p = 0.021) with clinically-relevant improvements in 53.7% of PedPRM-treated versus 27.6% of placebo-treated subjects (p = 0.008). Caregivers' quality of life also improved with PedPRM versus placebo (p = 0.010) and correlated with the change in total SDQ (p = 0.0005). PedPRM alleviates insomnia-related difficulties, particularly externalizing behavior in the children, subsequently improving caregivers' quality of life. En ligne : http://dx.doi.org/10.1007/s10803-019-04046-5 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=403

---

1 (1 - 2 / 2) Par page : 25 50 100 200